DIF Capital Partners, through its DIF Infrastructure Fund VI, announced the purchase of two onshore wind farm projects with a combined capacity of 63 MW from OX2. PwC was the leading transaction advisor to DIF Capital Partners.
DIF Capital Partners is a leading global independent fund manager with €8.5 billion in assets. These funds have previously invested in solar and wind power farms with an output of approximately 2.3 GW in Europe, the Americas and Australia. The release states that on an annual basis, the total electricity generation will be around 200 GWh, which corresponds to the annual demand of around 50,000 households and will reduce CO2 emissions by 70,000 tonnes per year. The investment also supports the energy transition in Poland by increasing the installed capacity of RES projects and reducing the country's dependence on fossil fuel-based energy production.
The PwC team was led by Agnieszka Gajewska and Łukasz Stanecki in collaboration with Adam Kościelniak, Piotr Maślejek and the Financial Modelling team led by Piotr Rudzki and Bartłomiej Wójcik (together with Katarzyna Kocik, Paweł Poloczek, Kamil Cichacz) and the M&A team led by Adam Demusiak with the support of Andrzej Rusiniak.
This is the 5th RES transaction supported by PwC completed in 2021 alone. The acquisition of four operational onshore farms in 2 separate acquisition processes and the sale of interests in offshore wind farms were carried out by PwC's energy team led by Dorota Dębińska-Pokorska, acting as lead advisor in these processes.
At the beginning of 2021 the M&A Team of PwC Poland, for the second year in a row, leads the Mergermarket ranking for the Polish market by the number of transactions completed in 2020. Last year, as the lead transaction advisor (M&A), the PwC team headed by Adam Demusiak and Marcin Byrt finalised 14 transactions in Poland worth a total of more than PLN 4,0 billion (USD 1,0bn). PwC served as the lead advisor in transactions for shareholders of such entities as Corab, Masterchem, Veracomp, Pekao, Apaczka or Scanmed. The company worked also with top Private Equity funds, such as Innova, Abris, Aberdeen Standard, Permira, Carlyle and DIF, as well as with the leading capital groups, including Black Forest.